RRML - Vascular Endothelial Growth Factor Insertion/Deletion gene polymorphism in patients with type 2 diabetes and diabetic peripheral polyneuropathy
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- May 2024 -
 
A comprehensive review of Prof... 26
The role of nitro oxidative fa... 15
Effect of Systemic Inflammator... 15
Diagnostic value of stress myo... 14
Romanian Review of Laboratory ... 13
Evaluation of routine laborato... 13
Correlations of expressions of... 12
Monitoring the sensitivity of ... 11
Evaluation of cytotoxicity and... 10
Recomandarea comună EFLM-COLA... 9

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 22(2)/2014 DOI:10.2478/rrlm-2014-0023
XML
TXT

Vascular Endothelial Growth Factor Insertion/Deletion gene polymorphism in patients with type 2 diabetes and diabetic peripheral polyneuropathy

Adina Stoian, Anca Bacârea, Anca Moţăţăianu, Mircea Stoian, Florina Gliga, Vladimir Bacârea, Duicu Carmen, Claudia Bănescu


Abstract:

The aim of this work was to study for the first time in Romania Insertion/Deletion (I/D) polymorphism of the Vascular Endothelial Growth Factor (VEGF) gene in a group of patients with established type 2 diabetes mellitus (DM) and diabetic peripheral neuropathy (DPN) compared with a control group. This was a case-control study consisting of a group of 84 patients with type 2 DM and DPN, diagnosed by clinical neurological examination and electrophysiological nerve conduction studies and a control group of 90 healthy volunteers. For deoxyribonucleic acid (DNA) isolation, a DNA purification kit from Zymo Research was used. In vitro amplification of DNA sequences was achieved by polymerase chain reaction (PCR). Selective in vitro amplification of a DNA fragment of known sequence is based on the principle of extension of a primer (“primer and PCR amplicon”). DNA fragments were separated by gel electrophoresis. For proper viewing and interpreting of agarose gels Vilbert Lourmat system was used. D allele frequency of VEGF was significantly higher in patients with diabetic peripheral neuropathy (53.57%) compared with controls (25%), p=0.0001. There is a positive association between I/D polymorphism of VEGF gene and the presence of diabetic peripheral polyneuropathy. Our study suggests that D allele of VEGF gene is a risk factor for the occurrence of DPN.

Keywords: polyneuropathy, I/D polymorphism, VEGF gene, diabetes mellitus

Received: 17.6.2013
Accepted: 17.3.2014
Published: 25.5.2014

 
  PDF Download full text PDF
(338 KB)
     
 
How to cite
Stoian A, Bacârea A, Moţăţăianu A, Stoian M, Gliga F, Bacârea V, et al. Vascular Endothelial Growth Factor Insertion/Deletion gene polymorphism in patients with type 2 diabetes and diabetic peripheral polyneuropathy. Rev Romana Med Lab. 2014;22(2):165-72. DOI:10.2478/rrlm-2014-0023